Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)

Clinical Trial OPEN
Bielekova, Bibiana;
  • Publisher: nct

Objective: The primary goal of this study is to investigate the mechanism of action (MOA) of CD25-blocking therapies in high inflammatory multiple sclerosis (HI-MS). The secondary goal of this study is to assess long-term safety and efficacy of CD25-blocking therapies i... View more
Share - Bookmark

  • Download from
    OpenTrials via OpenTrials (Clinical Trial, 2010)
  • Cite this research data